|
 |
Carol Kruse's References
with links to PubMed
Representative Publications:
Zhang, J.G., Eguchi, J., Kruse, C.A., Gomez, G.G., Fakhrai, H., Schroter,
S., Ma, W., Hoa, N., Minev, B., Delgado, C., Wepsic, H.T., Okada, H., Jadus,
M.R.
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic
cell-based therapeutics.
Clin
Cancer Res. 2007 Jan 15;13(2 Pt 1):566-75.
Gomez, G.G., Kruse, C.A.
Cellular and functional characterization of immunoresistant human glioma cell
clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated
synthesis of biologically active TGF-beta.
J
Immunother (1997). 2007 Apr;30(3):261-73. Lund, C.V., Giese, M., Owens, G.C., Pakchoian, A., Shaterian, A., Kruse,
C.A., Eliceiri, B.P.
Reduced glioma infiltration in Src-deficient mice.
J Neurooncol. 2006 May;78(1):19-29.
Gomez, G.G., Varella-Garcia, M.-L., Kruse, C.A.
Isolation of Immunoresistant
Human Glioma Cell Clones after Immunoselection with Alloreactive Cytotoxic
T Lymphocytes: Cytogenetic and Molecular Cytogenetic Characterization.
Cancer Genet Cytogenet. 2006 Mar;165(2):121-34.
Gomez, G.G., Kruse, C.A.
Mechanisms of malignant glioma immune resistance and sources of immunosuppression.
Gene
Ther Mol Biol. 2006;10(a):133-146. Tritz, R., Habita, C., Robbins, J.M., Gomez, G.G., Kruse, C.A.
Catalytic nucleic acid enzymes for the study and development of therapies in
the central nervous system.
Gene
Ther Mol Biol. 2005;9A:89-106. Paul, D.B., Read, S.B., Kulprathipanja, N., Gomez, G.G., Kleinschmidt-DeMasters,
B.K., Schiltz, P.M., Kruse, C.A.
Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and
its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.
J
Neurooncol. 2003 Aug-Sep;64(1-2):89-99.
Burrows, F.J., Gore, M., Smiley,
W.R., Kanemitsu, M.Y., Jolly, D.R., Read, S.B., Nicholas, T., Kruse,CA.
Purified Herpes simplex thymidine kinase retroviral particles. III. Characterization
of bystander killing mechanisms in transfected tumor cells.
Cancer
Gene Ther, 2002 Jan 9(1), 87-95. Kruse, C.A., Rubinstein, D.
Cytotoxic T Lymphocytes Reactive to Patient Major Histocompatibility Proteins
for Therapy of Recurrent Primary Brain Tumors, in Brain Tumor Immunotherapy.
2001 Humana Press, pp 149-170. eds. D. Bigner, D.P. Becker, T.F. Cloughsey, and
L.M. Liau
|
